Checkpoint Therapeutics Statistics
Total Valuation
KLSE:TRIVE has a market cap or net worth of MYR 12.64 million. The enterprise value is -3.35 million.
Market Cap | 12.64M |
Enterprise Value | -3.35M |
Important Dates
The next estimated earnings date is Friday, September 26, 2025.
Earnings Date | Sep 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KLSE:TRIVE has 1.26 billion shares outstanding. The number of shares has increased by 0.00% in one year.
Current Share Class | 1.26B |
Shares Outstanding | 1.26B |
Shares Change (YoY) | +0.00% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 15.32% |
Owned by Institutions (%) | 26.29% |
Float | 745.83M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.94 |
PB Ratio | 0.11 |
P/TBV Ratio | 0.11 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.63 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 2.75 |
Financial Position
The company has a current ratio of 3.47
Current Ratio | 3.47 |
Quick Ratio | 3.47 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4,633.70 |
Financial Efficiency
Return on equity (ROE) is -4.58% and return on invested capital (ROIC) is -5.31%.
Return on Equity (ROE) | -4.58% |
Return on Assets (ROA) | -4.91% |
Return on Invested Capital (ROIC) | -5.31% |
Return on Capital Employed (ROCE) | -8.50% |
Revenue Per Employee | 813,592 |
Profits Per Employee | -666,546 |
Employee Count | 8 |
Asset Turnover | 0.05 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, KLSE:TRIVE has paid 226,226 in taxes.
Income Tax | 226,226 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.33% in the last 52 weeks. The beta is 1.19, so KLSE:TRIVE's price volatility has been higher than the market average.
Beta (5Y) | 1.19 |
52-Week Price Change | -83.33% |
50-Day Moving Average | 0.02 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 38.89 |
Average Volume (20 Days) | 2,361,060 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:TRIVE had revenue of MYR 6.51 million and -5.33 million in losses. Loss per share was -0.00.
Revenue | 6.51M |
Gross Profit | 1.29M |
Operating Income | -9.91M |
Pretax Income | -5.11M |
Net Income | -5.33M |
EBITDA | -9.90M |
EBIT | -9.91M |
Loss Per Share | -0.00 |
Balance Sheet
The company has 15.98 million in cash and n/a in debt, giving a net cash position of 15.98 million or 0.01 per share.
Cash & Cash Equivalents | 15.98M |
Total Debt | n/a |
Net Cash | 15.98M |
Net Cash Per Share | 0.01 |
Equity (Book Value) | 113.78M |
Book Value Per Share | 0.09 |
Working Capital | 23.10M |
Cash Flow
In the last 12 months, operating cash flow was -1.21 million and capital expenditures -342, giving a free cash flow of -1.21 million.
Operating Cash Flow | -1.21M |
Capital Expenditures | -342 |
Free Cash Flow | -1.21M |
FCF Per Share | -0.00 |
Margins
Gross margin is 19.80%, with operating and profit margins of -152.21% and -81.93%.
Gross Margin | 19.80% |
Operating Margin | -152.21% |
Pretax Margin | -78.45% |
Profit Margin | -81.93% |
EBITDA Margin | -152.07% |
EBIT Margin | -152.21% |
FCF Margin | n/a |
Dividends & Yields
KLSE:TRIVE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.00% |
Shareholder Yield | n/a |
Earnings Yield | -42.20% |
FCF Yield | -9.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on December 22, 2020. It was a reverse split with a ratio of 0.04.
Last Split Date | Dec 22, 2020 |
Split Type | Reverse |
Split Ratio | 0.04 |
Scores
KLSE:TRIVE has an Altman Z-Score of 2.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.94 |
Piotroski F-Score | 1 |